JNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc Litigation
Johnson & Johnson (JNJ) said on Monday it had reached an agreement with plaintiffs' lawyers on a proposed resolution of the remaining U.S. lawsuits alleging its talc products caused ovarian cancer, committing $5.5 billion to settle around 76,000 claims.The healthcare company said the agreement cove…